Abstract

Each year, 17,700 Americans suffer a spinal cord injury, over half of which occur at the cervical level. These high level injuries can interrupt bulbospinal neurons that innervate the phrenic motornucleus, the origin of the phrenic nerve. Loss of these descending inputs to the phrenic nerve paralyzes the ipsilateral diaphragm, leading to breathing impairments. One approach to promote recovery of breathing function is by enhancing plasticity through strengthening of synapses or activating spared but latent pathways in the spinal cord. Activation of the latent crossed phrenic pathway can lead to a form of respiratory motor plasticity known as long term facilitation (LTF), which is characterized by a prolonged increase in breathing motor output. LTF can be induced through exposure to intermittent hypoxia (IH) or by intermittently dosing the spinal cord with serotonin (5‐HT). While a portion of the spinal cord injured population responds to IH therapy with the expected increase in respiratory output, others remain non‐responders. This inconsistency indicates that variability in the human population may influence how individuals respond to treatments that aim to enhance plasticity. Therefore, we propose that genetic diversity among the SCI population could be a key factor in determining an individual's propensity for plasticity. Apolipoprotein E (apoE) is a promising candidate gene that could be responsible for this variability because one of the apoE alleles, E4, has previously been shown to reduce synaptic plasticity by decreasing expression of glutamate receptors when compared to the E2 or E3 alleles. The present study investigates the influence of human apoE4 on respiratory motor plasticity in rats following C2 hemisection. 20 weeks after injury, rats were dosed with one isoform of the human apoE protein, E3 or E4, prior to receiving intermittent 5‐HT to induce LTF. Diaphragmatic EMG recordings demonstrated that animals exposed to human apoE3 protein exhibited an increase in diaphragmatic activity ipsilateral to the injury, but this increase was abolished in E4 dosed animals. Analysis of tissue dosed with human apoE protein indicated that apoE also modulates synaptic expression of glutamate receptors, a crucial component of LTF induction. Collectively, these experiments demonstrate ApoE4's potential to inhibit plasticity following spinal cord injury, emphasizing the importance of considering genetic diversity while developing SCI therapeutics for the human population.Support or Funding InformationNational Science Foundation Graduate Research Fellowship, University of Kentucky College of Medicine Fellowship for Excellence in Graduate Research, University of Kentucky Startup FundsThis abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call